341 related articles for article (PubMed ID: 24560688)
1. Chemical kinetics for drug discovery to combat protein aggregation diseases.
Arosio P; Vendruscolo M; Dobson CM; Knowles TP
Trends Pharmacol Sci; 2014 Mar; 35(3):127-35. PubMed ID: 24560688
[TBL] [Abstract][Full Text] [Related]
2. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
3. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
Pain C; Dumont J; Dumoulin M
Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
[TBL] [Abstract][Full Text] [Related]
4. In vivo aspects of protein folding and quality control.
Balchin D; Hayer-Hartl M; Hartl FU
Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
[TBL] [Abstract][Full Text] [Related]
5. Protein misfolding in disease and small molecule therapies.
Gomes CM
Curr Top Med Chem; 2012; 12(22):2460-9. PubMed ID: 23339300
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic strategies for targeting neurodegenerative protein misfolding disorders.
Scannevin RH
Curr Opin Chem Biol; 2018 Jun; 44():66-74. PubMed ID: 29902695
[TBL] [Abstract][Full Text] [Related]
7. Karyopherin abnormalities in neurodegenerative proteinopathies.
Pasha T; Zatorska A; Sharipov D; Rogelj B; Hortobágyi T; Hirth F
Brain; 2021 Nov; 144(10):2915-2932. PubMed ID: 34019093
[TBL] [Abstract][Full Text] [Related]
8. Bacteria-Derived Protein Aggregates Contribute to the Disruption of Host Proteostasis.
Walker AC; Bhargava R; Dove AS; Brust AS; Owji AA; Czyż DM
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563197
[TBL] [Abstract][Full Text] [Related]
9. Aptamer and its applications in neurodegenerative diseases.
Qu J; Yu S; Zheng Y; Zheng Y; Yang H; Zhang J
Cell Mol Life Sci; 2017 Feb; 74(4):683-695. PubMed ID: 27563707
[TBL] [Abstract][Full Text] [Related]
10. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
Maiti P; Manna J; Veleri S; Frautschy S
Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of aggregate formation as therapeutic target in protein misfolding diseases: effect of tetracycline and trehalose.
Sirangelo I; Irace G
Expert Opin Ther Targets; 2010 Dec; 14(12):1311-21. PubMed ID: 21058920
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamic and kinetic approaches for drug discovery to target protein misfolding and aggregation.
Vendruscolo M
Expert Opin Drug Discov; 2023; 18(8):881-891. PubMed ID: 37276120
[TBL] [Abstract][Full Text] [Related]
13. Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity.
Thellung S; Corsaro A; Nizzari M; Barbieri F; Florio T
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791416
[TBL] [Abstract][Full Text] [Related]
14. Phthalocyanines as Molecular Scaffolds to Block Disease-Associated Protein Aggregation.
Valiente-Gabioud AA; Miotto MC; Chesta ME; Lombardo V; Binolfi A; Fernández CO
Acc Chem Res; 2016 May; 49(5):801-8. PubMed ID: 27136297
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of protein misfolding and aggregation by natural phenolic compounds.
Dhouafli Z; Cuanalo-Contreras K; Hayouni EA; Mays CE; Soto C; Moreno-Gonzalez I
Cell Mol Life Sci; 2018 Oct; 75(19):3521-3538. PubMed ID: 30030591
[TBL] [Abstract][Full Text] [Related]
16. Small molecules that target protein misfolding.
Gavrin LK; Denny RA; Saiah E
J Med Chem; 2012 Dec; 55(24):10823-43. PubMed ID: 23075044
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathways to polyglutamine aggregation.
Robertson AL; Bottomley SP
Adv Exp Med Biol; 2012; 769():115-24. PubMed ID: 23560307
[TBL] [Abstract][Full Text] [Related]
18. Identification of Natural Products as Potential Pharmacological Chaperones for Protein Misfolding Diseases.
Sharma R; Srivastava T; Pandey AR; Mishra T; Gupta B; Reddy SS; Singh SP; Narender T; Tripathi A; Chandramouli B; Sashidhara KV; Priya S; Kumar N
ChemMedChem; 2021 Jul; 16(13):2146-2156. PubMed ID: 33760394
[TBL] [Abstract][Full Text] [Related]
19. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
Chiti F; Dobson CM
Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive review of protein misfolding disorders, underlying mechanism, clinical diagnosis, and therapeutic strategies.
Basha S; Mukunda DC; Rodrigues J; Gail D'Souza M; Gangadharan G; Pai AR; Mahato KK
Ageing Res Rev; 2023 Sep; 90():102017. PubMed ID: 37468112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
